Less than 1 in 1,000 adolescents received gender-affirming medications: Study

1 day ago 5

Less than 1 in 1,000 adolescents with commercial insurance received gender-affirming medication over a five-year period, according to a study released Monday. The researchers in the study surveyed more than 5 million patients, ages 8 to 17, from 2018 to 2022. Of those who received a gender-related diagnosis, 926 received puberty blockers during that time…

*** Disclaimer: This Article is auto-aggregated by a Rss Api Program and has not been created or edited by Bdtype.

(Note: This is an unedited and auto-generated story from Syndicated News Rss Api. News.bdtype.com Staff may not have modified or edited the content body.

Please visit the Source Website that deserves the credit and responsibility for creating this content.)

Watch Live | Source Article